Tesamorelin/Ipamorelin 13/3MG

Tesamorelin/Ipamorelin 13mg/3mg

Tesamorelin/Ipamorelin 13mg/3mg combines two synergistic peptides—Tesamorelin, a Growth Hormone–Releasing Hormone (GHRH) analog, and Ipamorelin, a selective Growth Hormone–Releasing Peptide (GHRP). This combination offers a coordinated mechanism for growth hormone pathway research and endocrine signaling analysis in controlled laboratory environments.

Manufactured in a U.S. GMP-certified facility, this lyophilized formulation meets strict standards for purity, potency, and consistency.

Key Features

• Dual-pathway growth hormone signaling support through combined GHRH and GHRP mechanisms

• Selective pituitary receptor interaction associated with Ipamorelin

• High manufacturing standards ensuring batch consistency and quality

• Suitable for controlled laboratory research environments

Disclaimer

Tesamorelin/Ipamorelin is strictly intended for laboratory research purposes only. Regulatory authorities do not approve it for diagnostic, therapeutic, or human use. Qualified professionals must handle this product in accordance with all applicable laws and regulations.